IndraLab

Statements


AMPK inhibits KCNMA1. 2 / 2
| 2

reach
"Pharmacological activation of AMPK causes inhibition of maxiK channels, type I cell depolarization, a subsequent rise of [Ca 2+ ] i in type I cells and an activation of afferent sensory neurones of th[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"All effects of AICAR were fully reversed by the AMPK inhibitor compound C. MaxiK channels were also inhibited by the novel AMPK activator A-769662 and by intracellular dialysis with the constitutively active, truncated AMPK mutant, T172D."